Study on Inhibition of the Growth and Metastasis of LCID20 Hepatocellular Carcinoma by Capecitabine

周俭,汤钊猷,樊嘉,吴志全,纪元,王鲁,鲍卫华,邱双键

DOI: https://doi.org/10.3760/j.issn:1001-9030.2000.05.006

2000-01-01

Abstract:Objective To observe the inhibitory effect of Capecitabine(CAP),a new prodrug of 5-fluorouracil(5-Fu) on the growth and metastasis of LCID20, a highly metastatic hepatocellular carcinoma (HCC). Methods The protein level of platelet-derived endothelial cell growth factor (PD-ECGF) was determined by using immunohistochemical method in 61 cases of HCC. CAP and 5-Fu via oral administration were used in 18 nude mice bearing LCID20 tumor. All treatment lasted 3 weeks and the nude mice were killed 3 days after withdrawal of the drugs. The tumor size was calculated by using the formula: V=a×b 2×0.5. The AFP levels in the serum of the nude mice were detected by using radioimmunoassay. Lung metastasis was evaluated by HE staining in lung samples. The PD-ECGF staining and apoptosis in hepatoma were detected by using immunohistochemical method and TUNEL method respectively. Results The expression rate of PD-ECGF protein in 61 cases of HCC and paratumoral liver tissues was 70.5% and 47.5% respectively, and was higher in HCC tissues with advanced TNM stage (Stage I and II) than that in those with early TNM stage (Stage III and IV) (81.1% vs 54.2%, P 0.05). After the intervention by CAP, the tumor size (240±119) mm 3 was significantly smaller than that in the control (447±159) mm 3 and the 5-Fu group (442±81) mm 3 ( P 0.05); The AFP level was reduced markedly ( P 0.01 ); The lung metastasis rate was decreased obviously ( P 0.01); In the tumor tissue,the intense of PD-ECGF staining weakened and the apoptotic cells were increased ( P 0.01). Conclusion PD-ECGF was highly expressed in HCC. CAP could obviously inhibit the growth and metastasis of highly metastatic HCC.\;